GANNON STEVEN · Xenon Pharmaceuticals Inc. · 49d agono track record yet
Sold 10,000 @ $64.06 avg · $640,550 · 2026-08-11
Form 4: GANNON STEVEN sold XENE
GANNON STEVEN (Director at Xenon Pharmaceuticals Inc.) reported an open-market sale of 10,000 shares of XENE at an average $64.06, roughly $640,550, in a Form 4 filed 2026-08-13.
At post $64.23Now $39.75-38.1% since postedas of Sep 18, 4:31 PM ET
1d-2.9%
3d-2.9%
1w-7.0%
1m-8.7%
3m—
6m—
1y—